Rating Change
BNP Paribas analysts initiated coverage on West Pharmaceutical Services, Inc. (NYSE:WST) with a Outperform rating on July 13, 2026.
Rating Change BNP Paribas analysts initiated coverage on West Pharmaceutical Services, Inc. (NYSE:WST) with a Outperform rating on July 13, 2026. Market Context West…

BNP Paribas analysts initiated coverage on West Pharmaceutical Services, Inc. (NYSE:WST) with a Outperform rating on July 13, 2026.
West Pharmaceutical Services, Inc. operates in the Healthcare sector. The stock currently trades at $359.70 with a market capitalization of $19.6B. The stock has gained 30.5% over the past 52 weeks.
Analyst coverage from BNP Paribas provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for West Pharmaceutical Services, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 13, 2026 | BNP Paribas | Outperform | N/A |
| Jul 09, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Jul 06, 2026 | Evercore ISI Group | Outperform | N/A |
| Jul 02, 2026 | Keybanc | Overweight | N/A |
| Jun 09, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View WST Stock Page
A Outperform rating from BNP Paribas reflects the analyst's outlook on West Pharmaceutical Services, Inc. (NYSE:WST). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the WST forecast page.
Current market data
NYSE · WST
$341.11
Up: +$3.64 · +1.08%
Live quote updated
Keep reading
dividends ·
analyst ·
sec_filing ·
earnings ·